Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics and Psychiatric Care: A Review and Commentary
Merlin G. Butler
JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY (2018) Vol. 2, Iss. 2, pp. 17-24
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
Merlin G. Butler, Jennifer L. Miller, Janice L. Forster
Current Pediatric Reviews (2019) Vol. 15, Iss. 4, pp. 207-244
Open Access | Times Cited: 288
Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD)
Ann Genovese, Merlin G. Butler
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4726-4726
Open Access | Times Cited: 199
The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations
Ann Genovese, Merlin G. Butler
Genes (2023) Vol. 14, Iss. 3, pp. 677-677
Open Access | Times Cited: 100
A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics
João Xavier Santos, Célia Rasga, Ana Rita Marques, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 29
Of Mice and Men: The Inter-individual Variability of the Brain's Response to Drugs
Wolfgang Löscher
eNeuro (2024) Vol. 11, Iss. 2, pp. ENEURO.0518-23.2024
Open Access | Times Cited: 4
Behavioral and Psychiatric Disorders in Syndromic Autism
Ann Genovese, Merlin G. Butler
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 343-343
Open Access | Times Cited: 4
Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination
Francisco José Toja-Camba, Enrique Bandín‐Vilar, Gonzalo Hermelo-Vidal, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 104-104
Open Access | Times Cited: 3
Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions
Ravi Adinarayan Somabattini, Sahla Sherin, Brian Siva, et al.
Life Sciences (2024) Vol. 351, pp. 122806-122806
Closed Access | Times Cited: 3
Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome
Janice L. Forster, Jessica Duis, Merlin G. Butler
Genes (2021) Vol. 12, Iss. 2, pp. 152-152
Open Access | Times Cited: 19
Actionable Genomics in Clinical Practice: Paradigmatic Case Reports of Clinical and Therapeutic Strategies Based upon Genetic Testing
Merlin G. Butler, Daniel Moreno‐De‐Luca, Antonio M. Persico
Genes (2022) Vol. 13, Iss. 2, pp. 323-323
Open Access | Times Cited: 13
PGx in psychiatry: Patients’ knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing
Amanda Kastrinos, Gemme Campbell‐Salome, Summer Shelton, et al.
Patient Education and Counseling (2020) Vol. 104, Iss. 4, pp. 732-738
Open Access | Times Cited: 16
Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?
Jennifer Severe, John F. Greden, Priyanka Reddy
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 120-128
Open Access | Times Cited: 15
Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
Amrit Sandhu, Elnaz Naderi, Morenika Wijninga, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1354-1354
Open Access | Times Cited: 4
The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
Shivashankar H. Nagaraj, Maree Toombs
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 9
Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression
Farhana Islam, Ilona Gorbovskaya, Daniel J. Müller
Advances in experimental medicine and biology (2021), pp. 231-255
Closed Access | Times Cited: 5
The man whom clozapine (Clozaril) could not touch
Rebecca Shields
Cambridge University Press eBooks (2024), pp. 87-108
Closed Access
Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review
Andrej Belančić, Aristea Pavešić Radonja, Lana Ganoci, et al.
Croatian Medical Journal (2024) Vol. 65, Iss. 4, pp. 383-395
Open Access
A survey in Austria supports the significance of genetic counseling and pharmacogenetic testing for mental illness
Elena Aschauer, Shahriar Izadi Yazdi, H.N. Aschauer
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Pharmacogenomic Testing in Psychiatry
Gopalkumar Rakesh, Calvin R. Sumner, Jeanne Leventhal Alexander, et al.
The Journal of Nervous and Mental Disease (2019) Vol. 208, Iss. 2, pp. 127-130
Closed Access | Times Cited: 3
Commercial Aircraft-Assisted Suicide Accident Investigations Re-Visited—Agreeing to Disagree?
Alpo Vuorio, Robert Bor, Antti Sajantila, et al.
Safety (2023) Vol. 9, Iss. 1, pp. 17-17
Open Access | Times Cited: 1
Single Nucleotide Polymorphisms and Pharmacogenomics
Azher Arafah, Shafat Ali, Sabhiya Majid, et al.
Springer eBooks (2021), pp. 23-52
Closed Access | Times Cited: 2
An Automated Functional Annotation Pipeline That Rapidly Prioritizes Clinically Relevant Genes for Autism Spectrum Disorder
Olivia J. Veatch, Merlin G. Butler, Sarah H. Elsea, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9029-9029
Open Access | Times Cited: 1
Gender Trends in Psychotropic Medication Use in Autism
Christopher R. Huber, Zachary Fanaro, Varun Soti
Cureus (2022)
Open Access | Times Cited: 1
Implementing pharmacogenetics in private clinical settings
Mark Stengler
International Journal of Family & Community Medicine (2019) Vol. 3, Iss. 5
Open Access

Mark Stengler, Nmd Stengler
International Journal of Family & Community Medicine (2019) Vol. 3, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top